Accelerate Diagnostics
AXDX
#10564
Rank
โ‚น77.35 M
Marketcap
โ‚น3.06
Share price
0.00%
Change (1 day)
-97.88%
Change (1 year)

Accelerate Diagnostics (AXDX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น7.61 Billion

According to Accelerate Diagnostics's latest financial reports the company's total liabilities are โ‚น7.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น4.26 B-40.92%
2022-12-31โ‚น7.22 B-17.85%
2021-12-31โ‚น8.79 B-23.06%
2020-12-31โ‚น11.42 B13%
2019-12-31โ‚น10.11 B13.08%
2018-12-31โ‚น8.94 B1957.16%
2017-12-31โ‚น0.43 B27.02%
2016-12-31โ‚น0.34 B-18.34%
2015-12-31โ‚น0.41 B73.55%
2014-12-31โ‚น0.24 B104.21%
2013-12-31โ‚น0.11 B
2012-07-31โ‚น0.13 B106.64%
2011-07-31โ‚น64.04 M1.59%
2010-07-31โ‚น63.03 M-2.49%
2009-07-31โ‚น64.65 M6.69%
2008-07-31โ‚น60.59 M19.32%
2007-07-31โ‚น50.78 M-1.38%
2006-07-31โ‚น51.49 M-11.39%
2005-07-31โ‚น58.11 M27.23%
2004-07-31โ‚น45.67 M-2.49%
2003-07-31โ‚น46.84 M-24.8%
2002-07-31โ‚น62.29 M17.95%
2001-07-31โ‚น52.81 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น4.665 T 61,210.23%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น594.12 B 7,706.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚น2.647 T 34,687.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚น266.24 B 3,398.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
โ‚น29.26 B 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
โ‚น354.66 B 4,560.39%๐Ÿ‡บ๐Ÿ‡ธ USA